Skip to main content
SpringerLink
Log in

Perspektiven und Forschungspotenziale: Asthma

  • Chapter
Volkskrankheit Asthma/COPD

  • 2443 Accesses

Zusammenfassung

Asthma ist in Deutschland eine der häufigsten chronischen Erkrankungen. Asthma betrifft alle Altersgruppen und verursacht neben erheblichen direkten Kosten im Gesundheitswesen erhebliche indirekte Kosten [1]. Trotz eff ektiver antiasthmatischer Therapie wird das in Leitlinien fixierte Behandlungsziel einer vollständigen Asthmakontrolle auch in kontrollierten Studien nur ansatzweise erreicht [2]. Trotz einer prinzipiell möglichen guten Versorgung besteht dennoch eine erhebliche Morbidität [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Weißflog D, et al. (2001) Epidemiologie und Kosten von Asthma bronchiale und chronischer Bronchitis in Deutschland. DMW 126: 803–808

    Google Scholar 

  2. Bateman ED, et al. (2004) Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 170: 836–44

    Article  PubMed  Google Scholar 

  3. Rabe KF et al. (2000) Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16: 802–7

    Article  CAS  PubMed  Google Scholar 

  4. Virchow JC (1996) Asthma bronchiale: extrinsisch, intrinsisch oder gemischtförmig?. Wien Med Wochenschr. 146: 415–418

    PubMed  Google Scholar 

  5. Kalayci O, et al. (2006) ALOX5 promoter genotype, asthma severity and LTC production by eosinophils. Allergy 61: 97–103

    CAS  PubMed  Google Scholar 

  6. Eder W, et al (2006) The asthma epidemic. N Engl J Med 355: 2226–35

    Article  CAS  PubMed  Google Scholar 

  7. Virchow JC (2000) Intrinsic Asthma. In: Holgate ST & Busse WW (Eds.). Asthma and Rhinitis. 2nd Edition, 2 Volumes, 2014 pages, pp. 1335–1378. Blackwell Scientific Publications Oxford, 2000

    Google Scholar 

  8. Lange P, et al. (1998) A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339: 1194–200

    Article  CAS  PubMed  Google Scholar 

  9. Pepe C, et al (2005) Diff erences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116: 544–9

    Article  PubMed  Google Scholar 

  10. Virchow JC et al. (2007) Anticholinergic agents in asthma. In: Polosa R, Holgate ST, Hrsg. Therapeutic Strategies Asthma Current Treatments. Clinical publishing, Oxford 2007

    Google Scholar 

  11. Kleine-Tebbe J, et al. (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten Erkrankung. AllergoJournal 2006; 15:56–74

    Google Scholar 

  12. Guilbert TW (2006) Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354: 1985–97.

    Article  CAS  PubMed  Google Scholar 

  13. Cazzola M et al. (2005) Ultra long-acting ß2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin. Investig. Drugs 14: 775–783

    Article  CAS  PubMed  Google Scholar 

  14. Reynolds NA et al. (2004) Ciclesonide. Drugs 64: 511–519

    Article  CAS  PubMed  Google Scholar 

  15. Barnes PJ (2006) How corticosteroids control inflammation. Br. J. Pharmacol. 148: 245–254

    Article  CAS  PubMed  Google Scholar 

  16. Rosen J et al. (2005) The search for safer glucocorticoid receptor ligands. Endocr. Rev. 26: 452–464

    Article  CAS  PubMed  Google Scholar 

  17. Barnes PJ et al. (1998) Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50: 515–596

    CAS  PubMed  Google Scholar 

  18. Barnes PJ (2003) Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev. 14: 511–522

    Article  CAS  PubMed  Google Scholar 

  19. Berry MA, et al (2006) Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 354: 697–708

    Article  CAS  PubMed  Google Scholar 

  20. Bryan S et al. (2000) Effects of recombinant human interleukin-12 on eosinophils, airway hyperreactivity and the late asthmatic response. Lancet 356: 2149–2153

    Article  CAS  PubMed  Google Scholar 

  21. Erin EM et al. (2002) Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr. Drug Targets Inflamm. Allergy 1: 201–214

    CAS  Google Scholar 

  22. Bousquet J et al. (2006) Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 61: 72–78

    CAS  PubMed  Google Scholar 

  23. Duan W et al. (2005) Inhaled p38α mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 171: 571–578

    Article  PubMed  Google Scholar 

  24. Singh J et al. (2004) Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma. Curr. Top. Med. Chem. 4: 1497–1507

    Article  CAS  PubMed  Google Scholar 

  25. Stenton GR et al. (2002) Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase. J. Immunol. 169: 1028–1036

    CAS  PubMed  Google Scholar 

  26. Rosenwasser LJ et al. (2003) Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J. Allergy Clin. Immunol. 112: 563–570

    Article  PubMed  Google Scholar 

  27. Krieg AM (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug discov. 5: 471–484

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Pneumologie, Klinik für Innere Medizin, Ernst-Heydemann-Straße 6, 18057, Rostock

    Prof. Dr. J. Christian Virchow

Authors
  1. Prof. Dr. J. Christian Virchow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover

    Heidrun Lingner  & Friedrich-Wilhelm Schwartz  & 

  2. Fachklinik Allgäu, Peter-Heel-Straße 29, 87459, Pfronten-Ried

    Konrad Schultz

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Virchow, J.C. (2007). Perspektiven und Forschungspotenziale: Asthma. In: Lingner, H., Schwartz, FW., Schultz, K. (eds) Volkskrankheit Asthma/COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70920-6_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-70920-6_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-70919-0

  • Online ISBN: 978-3-540-70920-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation